ATE160357T1 - Neues antibiotikum, deoxymulündocandin, verfahren zu seiner produktion und verwendung als medikament - Google Patents

Neues antibiotikum, deoxymulündocandin, verfahren zu seiner produktion und verwendung als medikament

Info

Publication number
ATE160357T1
ATE160357T1 AT90125841T AT90125841T ATE160357T1 AT E160357 T1 ATE160357 T1 AT E160357T1 AT 90125841 T AT90125841 T AT 90125841T AT 90125841 T AT90125841 T AT 90125841T AT E160357 T1 ATE160357 T1 AT E160357T1
Authority
AT
Austria
Prior art keywords
deoxymulündocandin
medication
production
new antibiotic
antibiotic
Prior art date
Application number
AT90125841T
Other languages
English (en)
Inventor
Kirity Dr Roy
Triptikumar Dr Mukhopadhyay
Hans-Wolfram Dr Fehlhaber
Herbert Dr Kogler
Bimal Naresh Dr Ganguli
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of ATE160357T1 publication Critical patent/ATE160357T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT90125841T 1990-01-26 1990-12-31 Neues antibiotikum, deoxymulündocandin, verfahren zu seiner produktion und verwendung als medikament ATE160357T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90101538 1990-01-26

Publications (1)

Publication Number Publication Date
ATE160357T1 true ATE160357T1 (de) 1997-12-15

Family

ID=8203542

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90125841T ATE160357T1 (de) 1990-01-26 1990-12-31 Neues antibiotikum, deoxymulündocandin, verfahren zu seiner produktion und verwendung als medikament

Country Status (18)

Country Link
US (1) US5387670A (de)
EP (1) EP0438813B1 (de)
JP (1) JP3156232B2 (de)
KR (1) KR0172949B1 (de)
AT (1) ATE160357T1 (de)
AU (1) AU644838B2 (de)
CA (1) CA2034979C (de)
DE (1) DE69031730T2 (de)
DK (1) DK0438813T3 (de)
ES (1) ES2110405T3 (de)
FI (1) FI95602C (de)
GR (1) GR3025607T3 (de)
IE (1) IE910270A1 (de)
IL (1) IL97040A (de)
NO (1) NO179755C (de)
NZ (1) NZ236888A (de)
PT (1) PT96564B (de)
ZA (1) ZA91570B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009735A1 (en) * 1998-08-10 2000-02-24 Strobel Gary A A cyclic lipopeptide from cryptosporiopsis quercina possessing antifungal activity
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
CA2781666C (en) 2009-11-23 2017-02-21 Cubist Pharmaceuticals, Inc. Lipopeptide compositions and related methods
CN103074234B (zh) * 2012-12-25 2015-03-04 浙江工业大学 一株海洋真菌萨氏曲霉及其在制备抗肿瘤药物中的应用
CN112680360B (zh) * 2021-01-11 2021-10-15 青海师范大学 一株聚多曲霉菌及促进植物生长和防治植物病害的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182812A (en) * 1979-12-13 1985-02-19 Bernard J. Abbott Process for the preparation of derivatives of cyclic peptide nuclei

Also Published As

Publication number Publication date
JPH0530986A (ja) 1993-02-09
FI95602B (fi) 1995-11-15
KR0172949B1 (ko) 1999-02-01
US5387670A (en) 1995-02-07
AU6998691A (en) 1991-08-01
PT96564A (pt) 1991-10-15
EP0438813A1 (de) 1991-07-31
PT96564B (pt) 1998-07-31
KR910014398A (ko) 1991-08-31
FI95602C (fi) 1996-02-26
DE69031730T2 (de) 1998-04-23
NZ236888A (en) 1993-03-26
CA2034979A1 (en) 1991-07-27
IE910270A1 (en) 1991-07-31
ZA91570B (en) 1991-11-27
FI910366A0 (fi) 1991-01-24
AU644838B2 (en) 1993-12-23
JP3156232B2 (ja) 2001-04-16
NO179755C (no) 1996-12-11
ES2110405T3 (es) 1998-02-16
IL97040A0 (en) 1992-03-29
FI910366L (fi) 1991-07-27
DE69031730D1 (de) 1998-01-02
EP0438813B1 (de) 1997-11-19
DK0438813T3 (da) 1998-07-27
GR3025607T3 (en) 1998-03-31
NO179755B (no) 1996-09-02
NO910309L (no) 1991-07-29
CA2034979C (en) 2001-01-02
IL97040A (en) 1995-03-30
NO910309D0 (no) 1991-01-25

Similar Documents

Publication Publication Date Title
TW237455B (de)
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
DE69322007D1 (de) Carboxy substituierte phenylgruppe enthaltende carbapeneme; verfahren zu deren herstellung, zwischenprodukte und verwendung als antibiotika
DE69628804D1 (de) Substitutierte heterozyclische Derivate als CRF Antagonisten
DE69630777D1 (de) Bestimmte 1,4,5-trisubstituierte imidazoleverbindungen zur verwendung als cytokin
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
EA199800109A1 (ru) Производные азетидинона для лечения атеросклероза
DK0791007T3 (da) Antifungale sordaridinderivater
ATE236153T1 (de) 4-trifluormethyl-3-oxazolylpyridine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
GR3036070T3 (en) New process for the production of cephalosporines and novel intermediates in this process.
DE69031730D1 (de) Neues Antibiotikum, Deoxymulündocandin, Verfahren zu seiner Produktion und Verwendung als Medikament
TW327166B (en) Fluoromethoxy- or difluromethoxy-o-tolyl-acrylic acid derivatives
ATE235450T1 (de) 2-indanmethanolderivate und ihre verwendung als riechstoffe
ATE215561T1 (de) Methylsulfomycin 1, verfahren zu dessen herstellung und verwendung
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
ATE163010T1 (de) 4-(3-(4-oxothiazoldinyl)>butynylamine, verfahren zu deren herstellung und ihre verwendung als medikament
ATE158293T1 (de) Polycyclische 31668p- und 31668u-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als antibiotische oder antitumorale arzneistoffe
ATE269302T1 (de) 7-thiaprostaglandine und verfahren zu ihrer herstellung
ATE97447T1 (de) Antibiotikum 6270b, verfahren zu seiner herstellung und seine verwendung als anticoccidiosemittel und futterzusatz.
DE69000335D1 (de) Butalactin, verfahren zu seiner herstellung und seine verwendung als arzneimittel.
DE69417528D1 (de) Antibakterielles und als anti-tumormittel wirksames epoxidderivat dc 114-a1
DE3670079D1 (de) Azetidinderivate, verfahren zu ihrer herstellung und ihre verwendung als zwischenprodukte.
ATA95995A (de) Wasserfreies trinatriumcitrat, verfahren zu seiner herstellung und seine verwendung als trägermaterial
UY24326A1 (es) Nuevas piperidinas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time